Javascript doit fonctionner ! Activez-le et rechargez cette page.
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:hyperproliferation of effector t cells'
(id=6997907 ; fe=en:hyperproliferation of effector t cells ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=10116 creation date=2017-06-25 touchdate=2025-09-30 20:12:33.000)
≈ 163 relations sortantes

  1. en:hyperproliferation of effector t cells -- r_associated #0: 28 / 1 -> en:hashimoto thyroiditis
    n1=en:hyperproliferation of effector t cells | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=28
  2. en:hyperproliferation of effector t cells -- r_associated #0: 28 / 1 -> en:lymphocyte count normal
    n1=en:hyperproliferation of effector t cells | n2=en:lymphocyte count normal | rel=r_associated | relid=0 | w=28
  3. en:hyperproliferation of effector t cells -- r_associated #0: 27 / 0.964 -> en:recurrent upper respiratory tract infection
    n1=en:hyperproliferation of effector t cells | n2=en:recurrent upper respiratory tract infection | rel=r_associated | relid=0 | w=27
  4. en:hyperproliferation of effector t cells -- r_associated #0: 27 / 0.964 -> numération de lymphocytes normale
    n1=en:hyperproliferation of effector t cells | n2=numération de lymphocytes normale | rel=r_associated | relid=0 | w=27
  5. en:hyperproliferation of effector t cells -- r_associated #0: 26 / 0.929 -> en:foot ulcer
    n1=en:hyperproliferation of effector t cells | n2=en:foot ulcer | rel=r_associated | relid=0 | w=26
  6. en:hyperproliferation of effector t cells -- r_associated #0: 26 / 0.929 -> en:systemic lupus erythematosus
    n1=en:hyperproliferation of effector t cells | n2=en:systemic lupus erythematosus | rel=r_associated | relid=0 | w=26
  7. en:hyperproliferation of effector t cells -- r_associated #0: 25 / 0.893 -> cellules
    n1=en:hyperproliferation of effector t cells | n2=cellules | rel=r_associated | relid=0 | w=25
  8. en:hyperproliferation of effector t cells -- r_associated #0: 25 / 0.893 -> en:perirectal abscess
    n1=en:hyperproliferation of effector t cells | n2=en:perirectal abscess | rel=r_associated | relid=0 | w=25
  9. en:hyperproliferation of effector t cells -- r_associated #0: 24 / 0.857 -> en:fungal infection
    n1=en:hyperproliferation of effector t cells | n2=en:fungal infection | rel=r_associated | relid=0 | w=24
  10. en:hyperproliferation of effector t cells -- r_associated #0: 24 / 0.857 -> en:immunophenotyping
    n1=en:hyperproliferation of effector t cells | n2=en:immunophenotyping | rel=r_associated | relid=0 | w=24
  11. en:hyperproliferation of effector t cells -- r_associated #0: 24 / 0.857 -> en:recurrent bacterial infection
    n1=en:hyperproliferation of effector t cells | n2=en:recurrent bacterial infection | rel=r_associated | relid=0 | w=24
  12. en:hyperproliferation of effector t cells -- r_associated #0: 23 / 0.821 -> en:childhood-onset systemic lupus erythematosus
    n1=en:hyperproliferation of effector t cells | n2=en:childhood-onset systemic lupus erythematosus | rel=r_associated | relid=0 | w=23
  13. en:hyperproliferation of effector t cells -- r_associated #0: 23 / 0.821 -> en:lymphadenitis
    n1=en:hyperproliferation of effector t cells | n2=en:lymphadenitis | rel=r_associated | relid=0 | w=23
  14. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> adénite
    n1=en:hyperproliferation of effector t cells | n2=adénite | rel=r_associated | relid=0 | w=20
  15. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> allergie alimentaire
    n1=en:hyperproliferation of effector t cells | n2=allergie alimentaire | rel=r_associated | relid=0 | w=20
  16. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> Allergie alimentaire
    n1=en:hyperproliferation of effector t cells | n2=Allergie alimentaire | rel=r_associated | relid=0 | w=20
  17. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> antibody
    n1=en:hyperproliferation of effector t cells | n2=antibody | rel=r_associated | relid=0 | w=20
  18. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> anticorps
    n1=en:hyperproliferation of effector t cells | n2=anticorps | rel=r_associated | relid=0 | w=20
  19. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> antigène
    n1=en:hyperproliferation of effector t cells | n2=antigène | rel=r_associated | relid=0 | w=20
  20. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> arthrite
    n1=en:hyperproliferation of effector t cells | n2=arthrite | rel=r_associated | relid=0 | w=20
  21. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> arthropathie chronique dégénérative
    n1=en:hyperproliferation of effector t cells | n2=arthropathie chronique dégénérative | rel=r_associated | relid=0 | w=20
  22. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> arthrose
    n1=en:hyperproliferation of effector t cells | n2=arthrose | rel=r_associated | relid=0 | w=20
  23. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> asthma
    n1=en:hyperproliferation of effector t cells | n2=asthma | rel=r_associated | relid=0 | w=20
  24. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> asthme
    n1=en:hyperproliferation of effector t cells | n2=asthme | rel=r_associated | relid=0 | w=20
  25. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> déficit immunitaire combiné sévère
    n1=en:hyperproliferation of effector t cells | n2=déficit immunitaire combiné sévère | rel=r_associated | relid=0 | w=20
  26. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> dermatomyosite
    n1=en:hyperproliferation of effector t cells | n2=dermatomyosite | rel=r_associated | relid=0 | w=20
  27. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> dysgammaglobulinémie
    n1=en:hyperproliferation of effector t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20
  28. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:absent mucosal associated invariant t cells
    n1=en:hyperproliferation of effector t cells | n2=en:absent mucosal associated invariant t cells | rel=r_associated | relid=0 | w=20
  29. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:absent type 1 nk t cells
    n1=en:hyperproliferation of effector t cells | n2=en:absent type 1 nk t cells | rel=r_associated | relid=0 | w=20
  30. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:absolute lymphocyte count decreased
    n1=en:hyperproliferation of effector t cells | n2=en:absolute lymphocyte count decreased | rel=r_associated | relid=0 | w=20
  31. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:agammaglobulinemia
    n1=en:hyperproliferation of effector t cells | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=20
  32. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:allergic manifestations
    n1=en:hyperproliferation of effector t cells | n2=en:allergic manifestations | rel=r_associated | relid=0 | w=20
  33. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:allergy to eggs
    n1=en:hyperproliferation of effector t cells | n2=en:allergy to eggs | rel=r_associated | relid=0 | w=20
  34. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:anti-immune body
    n1=en:hyperproliferation of effector t cells | n2=en:anti-immune body | rel=r_associated | relid=0 | w=20
  35. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:anti-immune substance
    n1=en:hyperproliferation of effector t cells | n2=en:anti-immune substance | rel=r_associated | relid=0 | w=20
  36. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:anti-intermediary body
    n1=en:hyperproliferation of effector t cells | n2=en:anti-intermediary body | rel=r_associated | relid=0 | w=20
  37. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:antibody
    n1=en:hyperproliferation of effector t cells | n2=en:antibody | rel=r_associated | relid=0 | w=20
  38. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:antigen
    n1=en:hyperproliferation of effector t cells | n2=en:antigen | rel=r_associated | relid=0 | w=20
  39. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:arhrosis
    n1=en:hyperproliferation of effector t cells | n2=en:arhrosis | rel=r_associated | relid=0 | w=20
  40. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:arthragra
    n1=en:hyperproliferation of effector t cells | n2=en:arthragra | rel=r_associated | relid=0 | w=20
  41. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:arthritis
    n1=en:hyperproliferation of effector t cells | n2=en:arthritis | rel=r_associated | relid=0 | w=20
  42. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:asthma
    n1=en:hyperproliferation of effector t cells | n2=en:asthma | rel=r_associated | relid=0 | w=20
  43. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%)
    n1=en:hyperproliferation of effector t cells | n2=en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%) | rel=r_associated | relid=0 | w=20
  44. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:autoimmunity (rare)
    n1=en:hyperproliferation of effector t cells | n2=en:autoimmunity (rare) | rel=r_associated | relid=0 | w=20
  45. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:autoinflammation
    n1=en:hyperproliferation of effector t cells | n2=en:autoinflammation | rel=r_associated | relid=0 | w=20
  46. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:b-cell lymphocytosis, b-cell, polyclonal
    n1=en:hyperproliferation of effector t cells | n2=en:b-cell lymphocytosis, b-cell, polyclonal | rel=r_associated | relid=0 | w=20
  47. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:b-cell lymphopenia (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:b-cell lymphopenia (in some patients) | rel=r_associated | relid=0 | w=20
  48. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:blood poisoning
    n1=en:hyperproliferation of effector t cells | n2=en:blood poisoning | rel=r_associated | relid=0 | w=20
  49. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:blood-poisoning
    n1=en:hyperproliferation of effector t cells | n2=en:blood-poisoning | rel=r_associated | relid=0 | w=20
  50. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:bone marrow shows deficient granulopoiesis
    n1=en:hyperproliferation of effector t cells | n2=en:bone marrow shows deficient granulopoiesis | rel=r_associated | relid=0 | w=20
  51. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:candida albicans infections, chronic, recurrent
    n1=en:hyperproliferation of effector t cells | n2=en:candida albicans infections, chronic, recurrent | rel=r_associated | relid=0 | w=20
  52. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:chronic mucocutaneous candidiasis
    n1=en:hyperproliferation of effector t cells | n2=en:chronic mucocutaneous candidiasis | rel=r_associated | relid=0 | w=20
  53. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:congenital hypoplasia of thymus
    n1=en:hyperproliferation of effector t cells | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=20
  54. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:cutaneous anergy
    n1=en:hyperproliferation of effector t cells | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=20
  55. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decrease in granulocyte-specific cd16b (610665) isoform
    n1=en:hyperproliferation of effector t cells | n2=en:decrease in granulocyte-specific cd16b (610665) isoform | rel=r_associated | relid=0 | w=20
  56. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased alpha-beta cd8+ t cells (family b)
    n1=en:hyperproliferation of effector t cells | n2=en:decreased alpha-beta cd8+ t cells (family b) | rel=r_associated | relid=0 | w=20
  57. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased b cells
    n1=en:hyperproliferation of effector t cells | n2=en:decreased b cells | rel=r_associated | relid=0 | w=20
  58. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased b cells (family b)
    n1=en:hyperproliferation of effector t cells | n2=en:decreased b cells (family b) | rel=r_associated | relid=0 | w=20
  59. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased lymphocyte apoptosis
    n1=en:hyperproliferation of effector t cells | n2=en:decreased lymphocyte apoptosis | rel=r_associated | relid=0 | w=20
  60. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased natural killer cells
    n1=en:hyperproliferation of effector t cells | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=20
  61. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased serum iga
    n1=en:hyperproliferation of effector t cells | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=20
  62. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased serum igm
    n1=en:hyperproliferation of effector t cells | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=20
  63. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:decreased t cells
    n1=en:hyperproliferation of effector t cells | n2=en:decreased t cells | rel=r_associated | relid=0 | w=20
  64. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:defective t-cell proliferative responses
    n1=en:hyperproliferation of effector t cells | n2=en:defective t-cell proliferative responses | rel=r_associated | relid=0 | w=20
  65. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:defects in t-cell activation and proliferation
    n1=en:hyperproliferation of effector t cells | n2=en:defects in t-cell activation and proliferation | rel=r_associated | relid=0 | w=20
  66. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:degenerative arthritis
    n1=en:hyperproliferation of effector t cells | n2=en:degenerative arthritis | rel=r_associated | relid=0 | w=20
  67. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:dermatomyositis
    n1=en:hyperproliferation of effector t cells | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=20
  68. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:disseminated candidiasis
    n1=en:hyperproliferation of effector t cells | n2=en:disseminated candidiasis | rel=r_associated | relid=0 | w=20
  69. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:dysgammaglobulinemia
    n1=en:hyperproliferation of effector t cells | n2=en:dysgammaglobulinemia | rel=r_associated | relid=0 | w=20
  70. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:elevated il6 (147620)
    n1=en:hyperproliferation of effector t cells | n2=en:elevated il6 (147620) | rel=r_associated | relid=0 | w=20
  71. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:elevated il8 (146930)
    n1=en:hyperproliferation of effector t cells | n2=en:elevated il8 (146930) | rel=r_associated | relid=0 | w=20
  72. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:enterovirus infections
    n1=en:hyperproliferation of effector t cells | n2=en:enterovirus infections | rel=r_associated | relid=0 | w=20
  73. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:environmental illness
    n1=en:hyperproliferation of effector t cells | n2=en:environmental illness | rel=r_associated | relid=0 | w=20
  74. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:extremely low or absent t cells
    n1=en:hyperproliferation of effector t cells | n2=en:extremely low or absent t cells | rel=r_associated | relid=0 | w=20
  75. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:food allergy
    n1=en:hyperproliferation of effector t cells | n2=en:food allergy | rel=r_associated | relid=0 | w=20
  76. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:fungus disease
    n1=en:hyperproliferation of effector t cells | n2=en:fungus disease | rel=r_associated | relid=0 | w=20
  77. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:fungus infection
    n1=en:hyperproliferation of effector t cells | n2=en:fungus infection | rel=r_associated | relid=0 | w=20
  78. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:gastrointestinal allergy
    n1=en:hyperproliferation of effector t cells | n2=en:gastrointestinal allergy | rel=r_associated | relid=0 | w=20
  79. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:generalized enlarged lymph nodes
    n1=en:hyperproliferation of effector t cells | n2=en:generalized enlarged lymph nodes | rel=r_associated | relid=0 | w=20
  80. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy)
    n1=en:hyperproliferation of effector t cells | n2=en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy) | rel=r_associated | relid=0 | w=20
  81. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:henoch-schönlein purpura
    n1=en:hyperproliferation of effector t cells | n2=en:henoch-schönlein purpura | rel=r_associated | relid=0 | w=20
  82. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:hyperglobulinemia
    n1=en:hyperproliferation of effector t cells | n2=en:hyperglobulinemia | rel=r_associated | relid=0 | w=20
  83. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:hyperplasia of tonsils
    n1=en:hyperproliferation of effector t cells | n2=en:hyperplasia of tonsils | rel=r_associated | relid=0 | w=20
  84. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:hypogammaglobulinemia
    n1=en:hyperproliferation of effector t cells | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=20
  85. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:hypogammaglobulinemia (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=20
  86. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:hypogammaglobulinemia, profound
    n1=en:hyperproliferation of effector t cells | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=20
  87. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:ichoremia
    n1=en:hyperproliferation of effector t cells | n2=en:ichoremia | rel=r_associated | relid=0 | w=20
  88. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:igg, decreased
    n1=en:hyperproliferation of effector t cells | n2=en:igg, decreased | rel=r_associated | relid=0 | w=20
  89. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:igm deficiency
    n1=en:hyperproliferation of effector t cells | n2=en:igm deficiency | rel=r_associated | relid=0 | w=20
  90. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immune body
    n1=en:hyperproliferation of effector t cells | n2=en:immune body | rel=r_associated | relid=0 | w=20
  91. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immune deficiency (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:immune deficiency (in some patients) | rel=r_associated | relid=0 | w=20
  92. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immunoglobulin
    n1=en:hyperproliferation of effector t cells | n2=en:immunoglobulin | rel=r_associated | relid=0 | w=20
  93. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immunoglobulin a decreased
    n1=en:hyperproliferation of effector t cells | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=20
  94. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immunoglobulin a deficiency (disorder)
    n1=en:hyperproliferation of effector t cells | n2=en:immunoglobulin a deficiency (disorder) | rel=r_associated | relid=0 | w=20
  95. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immunologic and autoimmune evaluation unremarkable
    n1=en:hyperproliferation of effector t cells | n2=en:immunologic and autoimmune evaluation unremarkable | rel=r_associated | relid=0 | w=20
  96. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:immunology
    n1=en:hyperproliferation of effector t cells | n2=en:immunology | rel=r_associated | relid=0 | w=20
  97. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:impaired antibody production (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:impaired antibody production (in some patients) | rel=r_associated | relid=0 | w=20
  98. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:impaired interferon production
    n1=en:hyperproliferation of effector t cells | n2=en:impaired interferon production | rel=r_associated | relid=0 | w=20
  99. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:impaired production of il17
    n1=en:hyperproliferation of effector t cells | n2=en:impaired production of il17 | rel=r_associated | relid=0 | w=20
  100. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:impaired production of interferon-gamma in response to mycobacterial infection
    n1=en:hyperproliferation of effector t cells | n2=en:impaired production of interferon-gamma in response to mycobacterial infection | rel=r_associated | relid=0 | w=20
  101. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes
    n1=en:hyperproliferation of effector t cells | n2=en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes | rel=r_associated | relid=0 | w=20
  102. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased ige level
    n1=en:hyperproliferation of effector t cells | n2=en:increased ige level | rel=r_associated | relid=0 | w=20
  103. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased igm level
    n1=en:hyperproliferation of effector t cells | n2=en:increased igm level | rel=r_associated | relid=0 | w=20
  104. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased igm levels, polyclonal
    n1=en:hyperproliferation of effector t cells | n2=en:increased igm levels, polyclonal | rel=r_associated | relid=0 | w=20
  105. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased nonspecific cd8+ t-cell proliferation
    n1=en:hyperproliferation of effector t cells | n2=en:increased nonspecific cd8+ t-cell proliferation | rel=r_associated | relid=0 | w=20
  106. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased serum ige
    n1=en:hyperproliferation of effector t cells | n2=en:increased serum ige | rel=r_associated | relid=0 | w=20
  107. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased susceptibility to candidal infections
    n1=en:hyperproliferation of effector t cells | n2=en:increased susceptibility to candidal infections | rel=r_associated | relid=0 | w=20
  108. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased susceptibility to certain viral infections
    n1=en:hyperproliferation of effector t cells | n2=en:increased susceptibility to certain viral infections | rel=r_associated | relid=0 | w=20
  109. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased susceptibility to herpes encephalitis
    n1=en:hyperproliferation of effector t cells | n2=en:increased susceptibility to herpes encephalitis | rel=r_associated | relid=0 | w=20
  110. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased susceptibility to mycobacteria and intracellular bacteria
    n1=en:hyperproliferation of effector t cells | n2=en:increased susceptibility to mycobacteria and intracellular bacteria | rel=r_associated | relid=0 | w=20
  111. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella
    n1=en:hyperproliferation of effector t cells | n2=en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella | rel=r_associated | relid=0 | w=20
  112. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:increased susceptibility to virus (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:increased susceptibility to virus (in some patients) | rel=r_associated | relid=0 | w=20
  113. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:lack of peripheral lymphoid tissue
    n1=en:hyperproliferation of effector t cells | n2=en:lack of peripheral lymphoid tissue | rel=r_associated | relid=0 | w=20
  114. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:low t cells
    n1=en:hyperproliferation of effector t cells | n2=en:low t cells | rel=r_associated | relid=0 | w=20
  115. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:lymphoid hyperplasia
    n1=en:hyperproliferation of effector t cells | n2=en:lymphoid hyperplasia | rel=r_associated | relid=0 | w=20
  116. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:markedly elevated iga
    n1=en:hyperproliferation of effector t cells | n2=en:markedly elevated iga | rel=r_associated | relid=0 | w=20
  117. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:mycobacterial infection
    n1=en:hyperproliferation of effector t cells | n2=en:mycobacterial infection | rel=r_associated | relid=0 | w=20
  118. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:mycosis
    n1=en:hyperproliferation of effector t cells | n2=en:mycosis | rel=r_associated | relid=0 | w=20
  119. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:neonatal sepsis
    n1=en:hyperproliferation of effector t cells | n2=en:neonatal sepsis | rel=r_associated | relid=0 | w=20
  120. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:normal serologic immunoglobulin production to vaccination
    n1=en:hyperproliferation of effector t cells | n2=en:normal serologic immunoglobulin production to vaccination | rel=r_associated | relid=0 | w=20
  121. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:opportunistic infection
    n1=en:hyperproliferation of effector t cells | n2=en:opportunistic infection | rel=r_associated | relid=0 | w=20
  122. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:osteoarthritis
    n1=en:hyperproliferation of effector t cells | n2=en:osteoarthritis | rel=r_associated | relid=0 | w=20
  123. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:periodic fevers (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:periodic fevers (in some patients) | rel=r_associated | relid=0 | w=20
  124. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:primary immune deficiency disorder
    n1=en:hyperproliferation of effector t cells | n2=en:primary immune deficiency disorder | rel=r_associated | relid=0 | w=20
  125. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:progressive loss of antibodies
    n1=en:hyperproliferation of effector t cells | n2=en:progressive loss of antibodies | rel=r_associated | relid=0 | w=20
  126. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:recurrent bacterial skin infections
    n1=en:hyperproliferation of effector t cells | n2=en:recurrent bacterial skin infections | rel=r_associated | relid=0 | w=20
  127. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:recurrent infections (otitis media and bacterial pneumonia)
    n1=en:hyperproliferation of effector t cells | n2=en:recurrent infections (otitis media and bacterial pneumonia) | rel=r_associated | relid=0 | w=20
  128. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:seasonal allergic rhinitis
    n1=en:hyperproliferation of effector t cells | n2=en:seasonal allergic rhinitis | rel=r_associated | relid=0 | w=20
  129. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:selective iga immunodeficiency
    n1=en:hyperproliferation of effector t cells | n2=en:selective iga immunodeficiency | rel=r_associated | relid=0 | w=20
  130. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:sensibilatrice
    n1=en:hyperproliferation of effector t cells | n2=en:sensibilatrice | rel=r_associated | relid=0 | w=20
  131. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:sepsis
    n1=en:hyperproliferation of effector t cells | n2=en:sepsis | rel=r_associated | relid=0 | w=20
  132. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:septic infection
    n1=en:hyperproliferation of effector t cells | n2=en:septic infection | rel=r_associated | relid=0 | w=20
  133. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:septicaema
    n1=en:hyperproliferation of effector t cells | n2=en:septicaema | rel=r_associated | relid=0 | w=20
  134. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:septicaemia
    n1=en:hyperproliferation of effector t cells | n2=en:septicaemia | rel=r_associated | relid=0 | w=20
  135. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:septicemia
    n1=en:hyperproliferation of effector t cells | n2=en:septicemia | rel=r_associated | relid=0 | w=20
  136. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:severe combined immunodeficiency
    n1=en:hyperproliferation of effector t cells | n2=en:severe combined immunodeficiency | rel=r_associated | relid=0 | w=20
  137. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:susceptibility to infection with influenza a infection
    n1=en:hyperproliferation of effector t cells | n2=en:susceptibility to infection with influenza a infection | rel=r_associated | relid=0 | w=20
  138. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:systemic infection
    n1=en:hyperproliferation of effector t cells | n2=en:systemic infection | rel=r_associated | relid=0 | w=20
  139. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy)
    n1=en:hyperproliferation of effector t cells | n2=en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy) | rel=r_associated | relid=0 | w=20
  140. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:systemic lupus erythematosus (in some patients)
    n1=en:hyperproliferation of effector t cells | n2=en:systemic lupus erythematosus (in some patients) | rel=r_associated | relid=0 | w=20
  141. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> en:t-cell lymphopenia
    n1=en:hyperproliferation of effector t cells | n2=en:t-cell lymphopenia | rel=r_associated | relid=0 | w=20
  142. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> État infectieux
    n1=en:hyperproliferation of effector t cells | n2=État infectieux | rel=r_associated | relid=0 | w=20
  143. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> état septique
    n1=en:hyperproliferation of effector t cells | n2=état septique | rel=r_associated | relid=0 | w=20
  144. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> État septique
    n1=en:hyperproliferation of effector t cells | n2=État septique | rel=r_associated | relid=0 | w=20
  145. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> fièvre des foins
    n1=en:hyperproliferation of effector t cells | n2=fièvre des foins | rel=r_associated | relid=0 | w=20
  146. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> hypogammaglobulinémie
    n1=en:hyperproliferation of effector t cells | n2=hypogammaglobulinémie | rel=r_associated | relid=0 | w=20
  147. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> immunodéficience combinée grave
    n1=en:hyperproliferation of effector t cells | n2=immunodéficience combinée grave | rel=r_associated | relid=0 | w=20
  148. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> immunoglobuline
    n1=en:hyperproliferation of effector t cells | n2=immunoglobuline | rel=r_associated | relid=0 | w=20
  149. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> immunologie
    n1=en:hyperproliferation of effector t cells | n2=immunologie | rel=r_associated | relid=0 | w=20
  150. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> infection à mycobactéries
    n1=en:hyperproliferation of effector t cells | n2=infection à mycobactéries | rel=r_associated | relid=0 | w=20
  151. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> infection généralisée
    n1=en:hyperproliferation of effector t cells | n2=infection généralisée | rel=r_associated | relid=0 | w=20
  152. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> infection systémique
    n1=en:hyperproliferation of effector t cells | n2=infection systémique | rel=r_associated | relid=0 | w=20
  153. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> lupus érythémateux systémique
    n1=en:hyperproliferation of effector t cells | n2=lupus érythémateux systémique | rel=r_associated | relid=0 | w=20
  154. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> lymphadénite
    n1=en:hyperproliferation of effector t cells | n2=lymphadénite | rel=r_associated | relid=0 | w=20
  155. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> maladie mycotique
    n1=en:hyperproliferation of effector t cells | n2=maladie mycotique | rel=r_associated | relid=0 | w=20
  156. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> maladie opportuniste
    n1=en:hyperproliferation of effector t cells | n2=maladie opportuniste | rel=r_associated | relid=0 | w=20
  157. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> mycose
    n1=en:hyperproliferation of effector t cells | n2=mycose | rel=r_associated | relid=0 | w=20
  158. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> mycosis
    n1=en:hyperproliferation of effector t cells | n2=mycosis | rel=r_associated | relid=0 | w=20
  159. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> sepsis
    n1=en:hyperproliferation of effector t cells | n2=sepsis | rel=r_associated | relid=0 | w=20
  160. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> septicémie
    n1=en:hyperproliferation of effector t cells | n2=septicémie | rel=r_associated | relid=0 | w=20
  161. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> septicémie du nouveau-né
    n1=en:hyperproliferation of effector t cells | n2=septicémie du nouveau-né | rel=r_associated | relid=0 | w=20
  162. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> septicémie néonatale
    n1=en:hyperproliferation of effector t cells | n2=septicémie néonatale | rel=r_associated | relid=0 | w=20
  163. en:hyperproliferation of effector t cells -- r_associated #0: 20 / 0.714 -> syndrome de Nezelof
    n1=en:hyperproliferation of effector t cells | n2=syndrome de Nezelof | rel=r_associated | relid=0 | w=20
≈ 239 relations entrantes

  1. numération de lymphocytes normale --- r_associated #0: 375 --> en:hyperproliferation of effector t cells
    n1=numération de lymphocytes normale | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=375
  2. en:lymphocyte count normal --- r_associated #0: 372 --> en:hyperproliferation of effector t cells
    n1=en:lymphocyte count normal | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=372
  3. en:antibody --- r_associated #0: 245 --> en:hyperproliferation of effector t cells
    n1=en:antibody | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=245
  4. anticorps --- r_associated #0: 241 --> en:hyperproliferation of effector t cells
    n1=anticorps | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=241
  5. infection généralisée --- r_associated #0: 229 --> en:hyperproliferation of effector t cells
    n1=infection généralisée | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=229
  6. sepsis --- r_associated #0: 222 --> en:hyperproliferation of effector t cells
    n1=sepsis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=222
  7. en:septicemia --- r_associated #0: 221 --> en:hyperproliferation of effector t cells
    n1=en:septicemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=221
  8. septicémie du nouveau-né --- r_associated #0: 220 --> en:hyperproliferation of effector t cells
    n1=septicémie du nouveau-né | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=220
  9. septicémie néonatale --- r_associated #0: 220 --> en:hyperproliferation of effector t cells
    n1=septicémie néonatale | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=220
  10. en:neonatal sepsis --- r_associated #0: 219 --> en:hyperproliferation of effector t cells
    n1=en:neonatal sepsis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=219
  11. en:sepsis --- r_associated #0: 209 --> en:hyperproliferation of effector t cells
    n1=en:sepsis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=209
  12. septicémie --- r_associated #0: 203 --> en:hyperproliferation of effector t cells
    n1=septicémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=203
  13. infection systémique --- r_associated #0: 175 --> en:hyperproliferation of effector t cells
    n1=infection systémique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=175
  14. en:hypogammaglobulinemia --- r_associated #0: 167 --> en:hyperproliferation of effector t cells
    n1=en:hypogammaglobulinemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=167
  15. hypogammaglobulinémie --- r_associated #0: 166 --> en:hyperproliferation of effector t cells
    n1=hypogammaglobulinémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=166
  16. antibody --- r_associated #0: 145 --> en:hyperproliferation of effector t cells
    n1=antibody | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=145
  17. allergie alimentaire --- r_associated #0: 120 --> en:hyperproliferation of effector t cells
    n1=allergie alimentaire | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=120
  18. en:food allergy --- r_associated #0: 118 --> en:hyperproliferation of effector t cells
    n1=en:food allergy | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=118
  19. état septique --- r_associated #0: 91 --> en:hyperproliferation of effector t cells
    n1=état septique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=91
  20. immunoglobuline --- r_associated #0: 85 --> en:hyperproliferation of effector t cells
    n1=immunoglobuline | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=85
  21. en:immunoglobulin --- r_associated #0: 84 --> en:hyperproliferation of effector t cells
    n1=en:immunoglobulin | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=84
  22. en:gastrointestinal allergy --- r_associated #0: 70 --> en:hyperproliferation of effector t cells
    n1=en:gastrointestinal allergy | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=70
  23. en:septicaemia --- r_associated #0: 68 --> en:hyperproliferation of effector t cells
    n1=en:septicaemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=68
  24. État septique --- r_associated #0: 61 --> en:hyperproliferation of effector t cells
    n1=État septique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=61
  25. arthrite --- r_associated #0: 55 --> en:hyperproliferation of effector t cells
    n1=arthrite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=55
  26. en:arthritis --- r_associated #0: 51 --> en:hyperproliferation of effector t cells
    n1=en:arthritis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=51
  27. en:mycosis --- r_associated #0: 50 --> en:hyperproliferation of effector t cells
    n1=en:mycosis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=50
  28. mycose --- r_associated #0: 50 --> en:hyperproliferation of effector t cells
    n1=mycose | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=50
  29. déficit immunitaire combiné sévère --- r_associated #0: 49 --> en:hyperproliferation of effector t cells
    n1=déficit immunitaire combiné sévère | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=49
  30. en:blood-poisoning --- r_associated #0: 49 --> en:hyperproliferation of effector t cells
    n1=en:blood-poisoning | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=49
  31. en:fungal infection --- r_associated #0: 49 --> en:hyperproliferation of effector t cells
    n1=en:fungal infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=49
  32. en:septicaema --- r_associated #0: 49 --> en:hyperproliferation of effector t cells
    n1=en:septicaema | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=49
  33. en:septic infection --- r_associated #0: 47 --> en:hyperproliferation of effector t cells
    n1=en:septic infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=47
  34. en:severe combined immunodeficiency --- r_associated #0: 46 --> en:hyperproliferation of effector t cells
    n1=en:severe combined immunodeficiency | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=46
  35. en:sensibilatrice --- r_associated #0: 45 --> en:hyperproliferation of effector t cells
    n1=en:sensibilatrice | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=45
  36. État infectieux --- r_associated #0: 45 --> en:hyperproliferation of effector t cells
    n1=État infectieux | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=45
  37. arthrose --- r_associated #0: 44 --> en:hyperproliferation of effector t cells
    n1=arthrose | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=44
  38. mycosis --- r_associated #0: 44 --> en:hyperproliferation of effector t cells
    n1=mycosis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=44
  39. en:extremely low or absent t cells --- r_associated #0: 43 --> en:hyperproliferation of effector t cells
    n1=en:extremely low or absent t cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=43
  40. en:recurrent bacterial infection --- r_associated #0: 43 --> en:hyperproliferation of effector t cells
    n1=en:recurrent bacterial infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=43
  41. en:anti-intermediary body --- r_associated #0: 42 --> en:hyperproliferation of effector t cells
    n1=en:anti-intermediary body | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=42
  42. en:arthragra --- r_associated #0: 42 --> en:hyperproliferation of effector t cells
    n1=en:arthragra | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=42
  43. en:increased serum ige --- r_associated #0: 42 --> en:hyperproliferation of effector t cells
    n1=en:increased serum ige | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=42
  44. en:ichoremia --- r_associated #0: 41 --> en:hyperproliferation of effector t cells
    n1=en:ichoremia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=41
  45. maladie mycotique --- r_associated #0: 41 --> en:hyperproliferation of effector t cells
    n1=maladie mycotique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=41
  46. Allergie alimentaire --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=Allergie alimentaire | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  47. asthme --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=asthme | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  48. en:asthma --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=en:asthma | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  49. en:hyperplasia of tonsils --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=en:hyperplasia of tonsils | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  50. en:immunoglobulin a deficiency (disorder) --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=en:immunoglobulin a deficiency (disorder) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  51. en:increased susceptibility to virus (in some patients) --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=en:increased susceptibility to virus (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  52. immunologie --- r_associated #0: 40 --> en:hyperproliferation of effector t cells
    n1=immunologie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=40
  53. en:arhrosis --- r_associated #0: 39 --> en:hyperproliferation of effector t cells
    n1=en:arhrosis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=39
  54. arthropathie chronique dégénérative --- r_associated #0: 38 --> en:hyperproliferation of effector t cells
    n1=arthropathie chronique dégénérative | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=38
  55. en:fungus disease --- r_associated #0: 38 --> en:hyperproliferation of effector t cells
    n1=en:fungus disease | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=38
  56. en:fungus infection --- r_associated #0: 38 --> en:hyperproliferation of effector t cells
    n1=en:fungus infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=38
  57. adénites --- r_associated #0: 37 --> en:hyperproliferation of effector t cells
    n1=adénites | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=37
  58. asthma --- r_associated #0: 37 --> en:hyperproliferation of effector t cells
    n1=asthma | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=37
  59. en:elevated il6 (147620) --- r_associated #0: 37 --> en:hyperproliferation of effector t cells
    n1=en:elevated il6 (147620) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=37
  60. en:immunology --- r_associated #0: 37 --> en:hyperproliferation of effector t cells
    n1=en:immunology | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=37
  61. en:impaired production of il17 --- r_associated #0: 37 --> en:hyperproliferation of effector t cells
    n1=en:impaired production of il17 | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=37
  62. syndrome de Nezelof --- r_associated #0: 37 --> en:hyperproliferation of effector t cells
    n1=syndrome de Nezelof | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=37
  63. en:anti-immune body --- r_associated #0: 36 --> en:hyperproliferation of effector t cells
    n1=en:anti-immune body | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=36
  64. en:systemic infection --- r_associated #0: 36 --> en:hyperproliferation of effector t cells
    n1=en:systemic infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=36
  65. en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%) --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:autoimmune disease resembling systemic lupus erythematosus (sle, 152700) (in about 26%) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  66. en:childhood-onset systemic lupus erythematosus --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:childhood-onset systemic lupus erythematosus | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  67. en:decreased b cells (family b) --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:decreased b cells (family b) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  68. en:hypogammaglobulinemia (in some patients) --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:hypogammaglobulinemia (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  69. en:igm deficiency --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:igm deficiency | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  70. en:impaired production of interferon-gamma in response to mycobacterial infection --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:impaired production of interferon-gamma in response to mycobacterial infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  71. en:increased susceptibility to herpes encephalitis --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:increased susceptibility to herpes encephalitis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  72. en:perirectal abscess --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:perirectal abscess | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  73. en:progressive loss of antibodies --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:progressive loss of antibodies | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  74. en:recurrent infections (otitis media and bacterial pneumonia) --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:recurrent infections (otitis media and bacterial pneumonia) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  75. en:seasonal allergic rhinitis --- r_associated #0: 35 --> en:hyperproliferation of effector t cells
    n1=en:seasonal allergic rhinitis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=35
  76. en:absent type 1 nk t cells --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:absent type 1 nk t cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  77. en:absolute lymphocyte count decreased --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:absolute lymphocyte count decreased | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  78. en:decreased lymphocyte apoptosis --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:decreased lymphocyte apoptosis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  79. en:elevated il8 (146930) --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:elevated il8 (146930) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  80. en:generalized enlarged lymph nodes --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:generalized enlarged lymph nodes | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  81. en:hyperglobulinemia --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:hyperglobulinemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  82. en:immune body --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:immune body | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  83. en:immune deficiency (in some patients) --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:immune deficiency (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  84. en:immunophenotyping --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:immunophenotyping | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  85. en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:increase in tlr2+ (603028)/tlr4- (603030) granulocytes | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  86. en:increased susceptibility to candidal infections --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:increased susceptibility to candidal infections | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  87. en:lack of peripheral lymphoid tissue --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:lack of peripheral lymphoid tissue | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  88. en:low t cells --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:low t cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  89. en:markedly elevated iga --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:markedly elevated iga | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  90. en:normal serologic immunoglobulin production to vaccination --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:normal serologic immunoglobulin production to vaccination | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  91. en:systemic lupus erythematosus --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:systemic lupus erythematosus | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  92. en:t-cell lymphopenia --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=en:t-cell lymphopenia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  93. lupus érythémateux aigu disséminé --- r_associated #0: 34 --> en:hyperproliferation of effector t cells
    n1=lupus érythémateux aigu disséminé | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=34
  94. en:anti-immune substance --- r_associated #0: 33 --> en:hyperproliferation of effector t cells
    n1=en:anti-immune substance | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=33
  95. en:cutaneous anergy --- r_associated #0: 32 --> en:hyperproliferation of effector t cells
    n1=en:cutaneous anergy | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
  96. en:decreased natural killer cells --- r_associated #0: 32 --> en:hyperproliferation of effector t cells
    n1=en:decreased natural killer cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
  97. en:impaired interferon production --- r_associated #0: 32 --> en:hyperproliferation of effector t cells
    n1=en:impaired interferon production | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
  98. en:increased igm levels, polyclonal --- r_associated #0: 32 --> en:hyperproliferation of effector t cells
    n1=en:increased igm levels, polyclonal | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
  99. en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy) --- r_associated #0: 32 --> en:hyperproliferation of effector t cells
    n1=en:systemic lupus erythematosus (in rare mutation carriers unaffected by a hematologic malignancy) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
  100. fièvre des foins --- r_associated #0: 32 --> en:hyperproliferation of effector t cells
    n1=fièvre des foins | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=32
  101. Ac --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=Ac | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  102. dysgammaglobulinémie --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=dysgammaglobulinémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  103. en:candida albicans infections, chronic, recurrent --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:candida albicans infections, chronic, recurrent | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  104. en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy) --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:granulomatous disease (in rare mutation carriers unaffected by a hematologic malignancy) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  105. en:immunoglobulin a decreased --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:immunoglobulin a decreased | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  106. en:immunologic and autoimmune evaluation unremarkable --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:immunologic and autoimmune evaluation unremarkable | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  107. en:lymphadenitis --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:lymphadenitis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  108. en:lymphoid hyperplasia --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:lymphoid hyperplasia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  109. en:selective iga immunodeficiency --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:selective iga immunodeficiency | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  110. en:susceptibility to infection with influenza a infection --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=en:susceptibility to infection with influenza a infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  111. lupus érythémateux systémique --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=lupus érythémateux systémique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  112. lymphadénite --- r_associated #0: 31 --> en:hyperproliferation of effector t cells
    n1=lymphadénite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31
  113. en:blood poisoning --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:blood poisoning | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  114. en:bone marrow shows deficient granulopoiesis --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:bone marrow shows deficient granulopoiesis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  115. en:chronic mucocutaneous candidiasis --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:chronic mucocutaneous candidiasis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  116. en:decreased serum iga --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:decreased serum iga | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  117. en:defective t-cell proliferative responses --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:defective t-cell proliferative responses | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  118. en:increased nonspecific cd8+ t-cell proliferation --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:increased nonspecific cd8+ t-cell proliferation | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  119. en:increased susceptibility to mycobacteria and intracellular bacteria --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:increased susceptibility to mycobacteria and intracellular bacteria | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  120. en:mycobacterial infection --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:mycobacterial infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  121. en:recurrent bacterial skin infections --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=en:recurrent bacterial skin infections | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  122. infection à mycobactéries --- r_associated #0: 30 --> en:hyperproliferation of effector t cells
    n1=infection à mycobactéries | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=30
  123. dermatomyosite --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=dermatomyosite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  124. en:absent mucosal associated invariant t cells --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:absent mucosal associated invariant t cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  125. en:autoinflammation --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:autoinflammation | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  126. en:b-cell lymphopenia (in some patients) --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:b-cell lymphopenia (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  127. en:decreased b cells --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:decreased b cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  128. en:degenerative arthritis --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:degenerative arthritis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  129. en:increased ige level --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:increased ige level | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  130. en:primary immune deficiency disorder --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=en:primary immune deficiency disorder | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  131. immunodéficience combinée grave --- r_associated #0: 29 --> en:hyperproliferation of effector t cells
    n1=immunodéficience combinée grave | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=29
  132. adénite --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=adénite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  133. antigène --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=antigène | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  134. en:agammaglobulinemia --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:agammaglobulinemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  135. en:allergy to eggs --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:allergy to eggs | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  136. en:antigen --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:antigen | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  137. en:decreased serum igm --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:decreased serum igm | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  138. en:defects in t-cell activation and proliferation --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:defects in t-cell activation and proliferation | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  139. en:dysgammaglobulinemia --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:dysgammaglobulinemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  140. en:hashimoto thyroiditis --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:hashimoto thyroiditis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  141. en:henoch-schönlein purpura --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:henoch-schönlein purpura | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  142. en:increased igm level --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:increased igm level | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  143. en:increased susceptibility to certain viral infections --- r_associated #0: 28 --> en:hyperproliferation of effector t cells
    n1=en:increased susceptibility to certain viral infections | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=28
  144. en:autoimmunity (rare) --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:autoimmunity (rare) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  145. en:congenital hypoplasia of thymus --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:congenital hypoplasia of thymus | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  146. en:decreased alpha-beta cd8+ t cells (family b) --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:decreased alpha-beta cd8+ t cells (family b) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  147. en:decreased t cells --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:decreased t cells | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  148. en:dermatomyositis --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:dermatomyositis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  149. en:disseminated candidiasis --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:disseminated candidiasis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  150. en:environmental illness --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:environmental illness | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  151. en:foot ulcer --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:foot ulcer | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  152. en:hypogammaglobulinemia, profound --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:hypogammaglobulinemia, profound | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  153. en:opportunistic infection --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:opportunistic infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  154. en:osteoarthritis --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:osteoarthritis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  155. en:periodic fevers (in some patients) --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:periodic fevers (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  156. en:recurrent upper respiratory tract infection --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:recurrent upper respiratory tract infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  157. en:systemic lupus erythematosus (in some patients) --- r_associated #0: 27 --> en:hyperproliferation of effector t cells
    n1=en:systemic lupus erythematosus (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=27
  158. en:allergic manifestations --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:allergic manifestations | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  159. en:b-cell lymphocytosis, b-cell, polyclonal --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:b-cell lymphocytosis, b-cell, polyclonal | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  160. en:decrease in granulocyte-specific cd16b (610665) isoform --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:decrease in granulocyte-specific cd16b (610665) isoform | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  161. en:enterovirus infections --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:enterovirus infections | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  162. en:igg, decreased --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:igg, decreased | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  163. en:impaired antibody production (in some patients) --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:impaired antibody production (in some patients) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  164. en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=en:increased susceptibility to systemic infections, particularly mycobacteria, candida, and salmonella | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  165. maladie opportuniste --- r_associated #0: 26 --> en:hyperproliferation of effector t cells
    n1=maladie opportuniste | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=26
  166. Asthme --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=Asthme | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  167. en:OA --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:OA | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  168. en:amynology --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:amynology | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  169. en:arthrosis --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:arthrosis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  170. en:degenerative joint disease --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:degenerative joint disease | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  171. en:immunoglobin --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:immunoglobin | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  172. en:osteoitis --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:osteoitis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  173. en:senescent arthritis --- r_associated #0: 25 --> en:hyperproliferation of effector t cells
    n1=en:senescent arthritis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=25
  174. allergie digestive --- r_associated #0: 24 --> en:hyperproliferation of effector t cells
    n1=allergie digestive | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=24
  175. en:hay fever --- r_associated #0: 23 --> en:hyperproliferation of effector t cells
    n1=en:hay fever | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=23
  176. en:yeast infection --- r_associated #0: 23 --> en:hyperproliferation of effector t cells
    n1=en:yeast infection | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=23
  177. AOD et NAOC --- r_associated #0: 22 --> en:hyperproliferation of effector t cells
    n1=AOD et NAOC | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=22
  178. adénite cervicale --- r_associated #0: 22 --> en:hyperproliferation of effector t cells
    n1=adénite cervicale | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=22
  179. adénopathie inflammatoire --- r_associated #0: 22 --> en:hyperproliferation of effector t cells
    n1=adénopathie inflammatoire | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=22
  180. en:Nezelof's syndrome --- r_associated #0: 22 --> en:hyperproliferation of effector t cells
    n1=en:Nezelof's syndrome | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=22
  181. syndrome de déficit en immunoglobulines --- r_associated #0: 22 --> en:hyperproliferation of effector t cells
    n1=syndrome de déficit en immunoglobulines | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=22
  182. agammaglobulinémie --- r_associated #0: 21 --> en:hyperproliferation of effector t cells
    n1=agammaglobulinémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=21
  183. allergies alimentaires --- r_associated #0: 21 --> en:hyperproliferation of effector t cells
    n1=allergies alimentaires | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=21
  184. en:hypertrophic arthritis --- r_associated #0: 21 --> en:hyperproliferation of effector t cells
    n1=en:hypertrophic arthritis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=21
  185. septicité --- r_associated #0: 21 --> en:hyperproliferation of effector t cells
    n1=septicité | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=21
  186. Septicémie --- r_associated #0: 20 --> en:hyperproliferation of effector t cells
    n1=Septicémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=20
  187. Allergies alimentaires --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=Allergies alimentaires | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  188. Arthrose --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=Arthrose | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  189. Hypogammaglobulinémie --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=Hypogammaglobulinémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  190. Mycose --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=Mycose | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  191. anti-corps --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=anti-corps | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  192. anticoagulant (médicament) --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=anticoagulant (médicament) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  193. anticoagulants oraux directs --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=anticoagulants oraux directs | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  194. anticodon --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=anticodon | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  195. anticoïncidence --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=anticoïncidence | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  196. antigen --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=antigen | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  197. en:anticodon --- r_associated #0: 15 --> en:hyperproliferation of effector t cells
    n1=en:anticodon | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=15
  198. Ag
    (antigène)
    --- r_associated #0: 10 --> en:hyperproliferation of effector t cells

    n1=Ag
    (antigène)
    | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  199. Antibody --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Antibody | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  200. Anticodon --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Anticodon | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  201. Anticorps --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Anticorps | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  202. Arthrite --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Arthrite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  203. Dermatomyosite --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Dermatomyosite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  204. Immunoglobuline --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Immunoglobuline | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  205. Immunologie --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Immunologie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  206. Lyme (neuropathies de la maladie de) --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Lyme (neuropathies de la maladie de) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  207. Lymphadénite --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Lymphadénite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  208. Nezelof (syndrome de) --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Nezelof (syndrome de) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  209. Sepsis --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Sepsis | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  210. Séoul (virus) --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=Séoul (virus) | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  211. ac --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=ac | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  212. arthrite sèche déformante --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=arthrite sèche déformante | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  213. asthmatique (maladie) et psychisme --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=asthmatique (maladie) et psychisme | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  214. en:agammaglobulinaemia --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:agammaglobulinaemia | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  215. en:anticoagulant --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:anticoagulant | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  216. en:anticoïncidence --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:anticoïncidence | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  217. en:digestive allergy --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:digestive allergy | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  218. en:gamma globulin --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:gamma globulin | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  219. en:immune globulin --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:immune globulin | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  220. en:septic nature --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:septic nature | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  221. en:septicity --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:septicity | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  222. en:shortness of breath --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:shortness of breath | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  223. en:suffocative catarrh --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:suffocative catarrh | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  224. en:wheeziness --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=en:wheeziness | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  225. immunoglobine --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=immunoglobine | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  226. maladie fongique --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=maladie fongique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  227. rhume des foins --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=rhume des foins | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  228. susceptibilité accrue à l'encéphalite herpétique --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=susceptibilité accrue à l'encéphalite herpétique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  229. vaginite --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=vaginite | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  230. état infectieux --- r_associated #0: 10 --> en:hyperproliferation of effector t cells
    n1=état infectieux | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=10
  231. Maladie opportuniste --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=Maladie opportuniste | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  232. adénopathie cervicale --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=adénopathie cervicale | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  233. anticoagulant circulant --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=anticoagulant circulant | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  234. anticoagulant circulant de type lupique --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=anticoagulant circulant de type lupique | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  235. anticomplémentaire --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=anticomplémentaire | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  236. candidose --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=candidose | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  237. diminution de l'apoptose des lymphocytes --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=diminution de l'apoptose des lymphocytes | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  238. diminution de la numération lymphocytaire absolue --- r_associated #0: 5 --> en:hyperproliferation of effector t cells
    n1=diminution de la numération lymphocytaire absolue | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=5
  239. % production --- r_associated #0: -5 --> en:hyperproliferation of effector t cells
    n1=% production | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=-5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr